Provided by Tiger Trade Technology Pte. Ltd.

Aldeyra Therapeutics

1.23
-0.0900-6.82%
Post-market: 1.260.0300+2.44%19:35 EDT
Volume:1.65M
Turnover:2.12M
Market Cap:74.00M
PE:-3.21
High:1.35
Open:1.34
Low:1.22
Close:1.32
52wk High:5.93
52wk Low:1.07
Shares:60.16M
Float Shares:48.93M
Volume Ratio:0.96
T/O Rate:3.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3836
EPS(LYR):-0.5636
ROE:-49.48%
ROA:-22.70%
PB:1.95
PE(LYR):-2.18

Loading ...

Aldeyra Therapeutics: Neutral Rating Maintained Amid FDA Uncertainty; $2 Price Target Reaffirmed

TIPRANKS
·
Yesterday

Aldeyra Therapeutics Price Target Maintained with a $9.00/Share by BTIG

Dow Jones
·
Yesterday

Aldeyra to submit Formal Dispute Resolution Request to FDA for reproxalap

TIPRANKS
·
Sep 29

Aldeyra sees operational cash runway into 2029

TIPRANKS
·
Sep 29

Aldeyra Extends Operational Cash Runway into 2029

Reuters
·
Sep 29

Aldeyra Therapeutics - Fdrr Submission and FDA Meeting Expected in Q4 2026

THOMSON REUTERS
·
Sep 29

Aldeyra Therapeutics Announces Intent to Submit Formal Dispute Resolution Request for Reproxalap to Treat Dry Eye Disease

THOMSON REUTERS
·
Sep 29

Aldeyra Therapeutics - Fdrr to Appeal March 16, 2026 Complete Response Letter Denying Nda for Reproxalap

THOMSON REUTERS
·
Sep 29

Aldeyra Therapeutics (ALDX) Receives a Hold from H.C. Wainwright

TIPRANKS
·
Sep 22

Aldeyra Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

Aldeyra Net Loss Narrows 44.2% to $5.45 Million in Q2 2026

Reuters
·
Aug 07

Aldeyra Therapeutics Inc Expected to Post a Loss of 9 Cents a Share - Earnings Preview

Reuters
·
Aug 04

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Jul 31

Aldeyra Therapeutics Leases New Concord Headquarters Space

TIPRANKS
·
Jul 31

Aldeyra Therapeutics Seeks FDA Clarification on Reproxalap NDA Meeting Minutes

MT Newswires Live
·
Jul 16

Aldeyra Therapeutics - to Request FDA Type D Meeting on Nda of Reproxalap Resubmission by End of Q3 2026 - SEC Filing

THOMSON REUTERS
·
Jul 16

Levicept Appoints Darlene Deptula-hicks as CFO

THOMSON REUTERS
·
Jul 07

Aldeyra Therapeutics director Darlene Deptula-Hicks files initial beneficial ownership statement

Reuters
·
Jun 12

Aldeyra Therapeutics appoints Darlene Deptula-Hicks to board of directors

Reuters
·
Jun 10

Aldeyra Therapeutics Appoints Darlene Deptula-Hicks to Board of Directors

THOMSON REUTERS
·
Jun 10